Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000556:secondary*